Researchers have profiled the entire immune system in young children to compare their response to SARS-CoV-2 with that of adults. The results, published in Cell, show that infants’ systems mount a strong innate response in their noses, where the airborne virus usually enters the body. And unlike adults, babies don’t exhibit widespread inflammatory signaling throughout their circulatory system, perhaps preventing severe COVID.
The research team, led by Stanford Medicine immunologist Bali Pulendran, took blood samples from 81 infants (54 of whom became infected with the virus between one month and three years of age) and dozens of adults. The researchers also took weekly nasal swabs from kids and adults with and without COVID. They then analyzed proteins and gene activity in these samples to track participants’ innate and adaptive immune responses to the virus. “This sort of longitudinal mapping of the immune response of infants, to any virus, had not been done before,” Pulendran says.
The team found stark differences between children and adults in both adaptive and innate immune responses. Infected infants’ noses were flooded with inflammatory signaling molecules and cells. But unlike in the adults, there were no signs of inflammation in their blood.
[…]
Even without a widespread innate response, young children had surprisingly long-lasting levels of SARS-specific antibodies in their blood, Pulendran says. Future research revealing how these innate and adaptive responses are linked could eventually help improve nasally delivered vaccines for children and, potentially, adults.
A crucial question remains: What makes SARS-CoV-2 different from other respiratory viruses, such as influenza and respiratory syncytial virus, which are more deadly for infants?
[…]
Source: Here’s Why Infants Are Strangely Resistant to COVID | Scientific American
Robin Edgar
Organisational Structures | Technology and Science | Military, IT and Lifestyle consultancy | Social, Broadcast & Cross Media | Flying aircraft